| 4-(5-methyl-3-phenyl-4-isoxazolyl)-benzenesulfonamide | |
| CAS number 181695-72-7 | ATC code M01AH03 |
| Chemical formula | C16H14N2O3S |
| Molecular weight | 314.364 |
| Bioavailability | 83% |
| Metabolism | 10% |
| Elimination half-life | 8-11 hours |
| Excretion | 90% |
| Pregnancy category | In late pregnancy, valdecoxib should be avoided because it may cause premature closure of the ductus arteriosus. |
| Legal status | Recalled in US, EU, Canada & parts of Asia |
| Routes of administration | 10mg Oral |
| Information Source: | |
Valdecoxib is a prescription drug used in the treatment of osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. It is classified as a nonsteroidal anti-inflammatory drug, or NSAID, and should not be taken by anyone allergic to these types of medications.
Valdecoxib was manufactured and marketed under the brand name Bextra® by G. D. Searle & Company. It was available by prescription in tablet form until 2005, when it was removed from the market due to concerns about possible increased risk of heart attack and stroke.
More on [ Valdecoxib ]

Haslam - Basic information on Bextra litigation from a Utah law firm.
Meta Description: [ Lawyers represent people who suffered a heart attack or stroke after use of Bextra. Includes lawsuit information and news on the recent FDA warning. ]
500
Miles, P.C. - Discussing possible legal remedies arising from the use of Bextra.
Meta Description: [ Beasley Allen Law Firm - If you or a loved one has been injured by Bextra, we can help! Free consultation. ]
Specter - Law firm site offering information about possible litigation over Bextra.
Meta Description: [ The Bextra attorneys at Kline and Specter represent victims of Bextra side effects including strokes and heart attacks. Lawyers handling Bextra lawsuits and claims throughout the U.S. ]
| Warnings for Bextra Strengthened (Feb 2003) | |
| Next Video | |